结直肠癌的放射组学研究进展
|
摘要
目的总结放射组学方法在结直肠癌诊治中的研究进展。方法复习使用放射组学方法对结直肠癌进行研究的相关文献,对放射组学在结直肠癌治疗方案的决策、疗效评价及预后评估方面的价值进行总结。结果放射组学在结直肠癌的术前分期、疗效评价及预后评估的不同阶段均有重要价值。结论放射组学是结直肠癌精准影像医学的重要组成部分。
Objective To summarize the application of radiomics in colorectal cancer. Methods Relevant literatures about the therapeutic decision-making, therapeutic, and prognostic evaluation of colorectal cancer using radiomics were collected to make an review. Results Radiomics is of great value in preoperative stages, therapeutic, and prognostic evaluation in colorectal cancer. Conclusion Radiomics is an important part of precision medical imaging for colorectal cancer.
Objective To summarize the application of radiomics in colorectal cancer. Methods Relevant literatures about the therapeutic decision-making, therapeutic, and prognostic evaluation of colorectal cancer using radiomics were collected to make an review. Results Radiomics is of great value in preoperative stages, therapeutic, and prognostic evaluation in colorectal cancer. Conclusion Radiomics is an important part of precision medical imaging for colorectal cancer.
引文
1Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015. CA Cancer J Clin, 2016, 66(2):115-132.
2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin, 2018, 68(1):7-30.
3王敏,宋彬,黄子星,等.大数据时代的精准影像医学:放射组学.中国普外基础与临床杂志, 2016, 23(6):752-755.
4 Yang L, Dong D, Fang M, et al. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? Eur Radiol, 2018, 28(5):2058-2067.
5Lee SJ, Zea R, Kim DH, et al. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer. Eur Radiol, 2018, 28(4):1520-1528.
6 Lovinfosse P, Polus M, Van Daele D, et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging, 2018, 45(3):365-375.
7Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer:radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology, 2018, 287(3):833-843.
8 Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics:extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48(4):441-446.
9Kumar V, Gu Y, Basu S, et al. Radiomics:the process and the challenges. Magn Reson Imaging, 2012, 30(9):1234-1248.
10 Gillies RJ, Kinahan PE, Hricak H. Radiomics:images are more than pictures, they are data. Radiology, 2016, 278(2):563-577.
11Fernández-Martos C, Pericay C, Aparicio J, et al. PhaseⅡ,randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin(CAPOX)compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imagingdefined, locally advanced rectal cancer:grupo cancer de recto 3study. J Clin Oncol, 2010, 28(5):859-865.
12 Liu L, Liu Y, Xu L, et al. Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer. J Magn Reson Imaging, 2017, 45(6):1798-1808.
13Liang C, Huang Y, He L, et al. The development and validation of a CT-based radiomics signature for the preoperative discrimination of stageⅠ-Ⅱand stageⅢ-Ⅳcolorectal cancer. Oncotarget, 2016,7(21):31401-31412.
14 钟红霞. MRI纹理分析在预测直肠癌NCRT疗效、TN分期、神经脉管侵犯方面的作用.北京:北京协和医学院, 2017.
15Langman G, Patel A, Bowley DM. Size and distribution of lymph nodes in rectal cancer resection specimens. Dis Colon Rectum2015, 58(4):406-414.
16 Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol, 2016, 34(18):2157-2164.
17van der Pool AE, Damhuis RA, Ijzermans JN, et al. Trends in incidence, treatment and survival of patients with stageⅣcolorectal cancer:a population-based series. Colorectal Dis, 201214(1):56-61.
18 Manfredi S, Lepage C, Hatem C, et al. Epidemiology and mana gement of liver metastases from colorectal cancer. Ann Surg, 2006244(2):254-259.
19Wakai T, Shirai Y, Sakata J, et al. Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis. Int J Clin Exp Pathol, 2012, 5(4):308-314.
20 Rao SX, Lambregts DM, Schnerr RS, et al. Whole-liver CT texture analysis in colorectal cancer:does the presence of liver metastasesaffect the texture of the remaining liver? United European Gastroenterol J, 2014, 2(6):530-538.
21Labianca R, Nordlinger B, Beretta GD, et al. Primary colon cancer:ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol, 2010, 21 Suppl 5:v70-v77.
22 Wu B, Yao Y, Zhang K, et al. RAS testing and cetuximab treatment for metastatic colorectal cancer:a cost-effectiveness analysis in a setting with limited health resources. Oncotarget, 2017, 8(41):71164-71172.
23王国蓉,王志伟,薛华丹,等. CT纹理分析对鉴别直肠癌患者K-ras基因突变的可行性研究.放射学实践, 2017, 32(12):1215-1220.
24 Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO-94 randomized phaseⅢtrial after a median follow-up of 11 years. J Clin Oncol, 2012,30(16):1926-1933.
25De Cecco CN, Ciolina M, Caruso D, et al. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR:initial experience. Abdom Radiol(NY), 2016, 41(9):1728-1735.
26 Nie K, Shi L, Chen Q, et al. Rectal cancer:assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res, 2016, 22(21):5256-5264.
27Nougaret S, Vargas HA, Lakhman Y, et al. Intravoxel incoherent motion-derived histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer:initial experience and comparison between single-section and volumetric analyses. Radiology, 2016, 280(2):446-454.
28 De Cecco CN, Ganeshan B, Ciolina M, et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol, 2015, 50(4):239-245.
29Jalil O, Afaq A, Ganeshan B, et al. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis, 2017, 19(4):349-362.
30 Ng F, Ganeshan B, Kozarski R, et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis:contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology, 2013, 266(1):177-184.
31Miles KA, Ganeshan B, Griffiths MR, et al. Colorectal cancer:texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology, 2009, 250(2):444-452.
32 Ganeshan B, Miles KA, Young RC, et al. Hepatic enhancement in colorectal cancer:texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol, 2007, 14(12):1520-1530.
33魏炜,刘振宇,王硕,等.影像组学技术研究进展及其在结直肠癌中的临床应用.中国生物医学工程学报, 2018, 37(5):513-520.
2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin, 2018, 68(1):7-30.
3王敏,宋彬,黄子星,等.大数据时代的精准影像医学:放射组学.中国普外基础与临床杂志, 2016, 23(6):752-755.
4 Yang L, Dong D, Fang M, et al. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? Eur Radiol, 2018, 28(5):2058-2067.
5Lee SJ, Zea R, Kim DH, et al. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer. Eur Radiol, 2018, 28(4):1520-1528.
6 Lovinfosse P, Polus M, Van Daele D, et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging, 2018, 45(3):365-375.
7Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer:radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology, 2018, 287(3):833-843.
8 Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics:extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48(4):441-446.
9Kumar V, Gu Y, Basu S, et al. Radiomics:the process and the challenges. Magn Reson Imaging, 2012, 30(9):1234-1248.
10 Gillies RJ, Kinahan PE, Hricak H. Radiomics:images are more than pictures, they are data. Radiology, 2016, 278(2):563-577.
11Fernández-Martos C, Pericay C, Aparicio J, et al. PhaseⅡ,randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin(CAPOX)compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imagingdefined, locally advanced rectal cancer:grupo cancer de recto 3study. J Clin Oncol, 2010, 28(5):859-865.
12 Liu L, Liu Y, Xu L, et al. Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer. J Magn Reson Imaging, 2017, 45(6):1798-1808.
13Liang C, Huang Y, He L, et al. The development and validation of a CT-based radiomics signature for the preoperative discrimination of stageⅠ-Ⅱand stageⅢ-Ⅳcolorectal cancer. Oncotarget, 2016,7(21):31401-31412.
14 钟红霞. MRI纹理分析在预测直肠癌NCRT疗效、TN分期、神经脉管侵犯方面的作用.北京:北京协和医学院, 2017.
15Langman G, Patel A, Bowley DM. Size and distribution of lymph nodes in rectal cancer resection specimens. Dis Colon Rectum2015, 58(4):406-414.
16 Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol, 2016, 34(18):2157-2164.
17van der Pool AE, Damhuis RA, Ijzermans JN, et al. Trends in incidence, treatment and survival of patients with stageⅣcolorectal cancer:a population-based series. Colorectal Dis, 201214(1):56-61.
18 Manfredi S, Lepage C, Hatem C, et al. Epidemiology and mana gement of liver metastases from colorectal cancer. Ann Surg, 2006244(2):254-259.
19Wakai T, Shirai Y, Sakata J, et al. Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis. Int J Clin Exp Pathol, 2012, 5(4):308-314.
20 Rao SX, Lambregts DM, Schnerr RS, et al. Whole-liver CT texture analysis in colorectal cancer:does the presence of liver metastasesaffect the texture of the remaining liver? United European Gastroenterol J, 2014, 2(6):530-538.
21Labianca R, Nordlinger B, Beretta GD, et al. Primary colon cancer:ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol, 2010, 21 Suppl 5:v70-v77.
22 Wu B, Yao Y, Zhang K, et al. RAS testing and cetuximab treatment for metastatic colorectal cancer:a cost-effectiveness analysis in a setting with limited health resources. Oncotarget, 2017, 8(41):71164-71172.
23王国蓉,王志伟,薛华丹,等. CT纹理分析对鉴别直肠癌患者K-ras基因突变的可行性研究.放射学实践, 2017, 32(12):1215-1220.
24 Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO-94 randomized phaseⅢtrial after a median follow-up of 11 years. J Clin Oncol, 2012,30(16):1926-1933.
25De Cecco CN, Ciolina M, Caruso D, et al. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR:initial experience. Abdom Radiol(NY), 2016, 41(9):1728-1735.
26 Nie K, Shi L, Chen Q, et al. Rectal cancer:assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res, 2016, 22(21):5256-5264.
27Nougaret S, Vargas HA, Lakhman Y, et al. Intravoxel incoherent motion-derived histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer:initial experience and comparison between single-section and volumetric analyses. Radiology, 2016, 280(2):446-454.
28 De Cecco CN, Ganeshan B, Ciolina M, et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol, 2015, 50(4):239-245.
29Jalil O, Afaq A, Ganeshan B, et al. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis, 2017, 19(4):349-362.
30 Ng F, Ganeshan B, Kozarski R, et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis:contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology, 2013, 266(1):177-184.
31Miles KA, Ganeshan B, Griffiths MR, et al. Colorectal cancer:texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology, 2009, 250(2):444-452.
32 Ganeshan B, Miles KA, Young RC, et al. Hepatic enhancement in colorectal cancer:texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol, 2007, 14(12):1520-1530.
33魏炜,刘振宇,王硕,等.影像组学技术研究进展及其在结直肠癌中的临床应用.中国生物医学工程学报, 2018, 37(5):513-520.